DaVita
DVA
#2016
Rank
S$12.81 B
Marketcap
S$191.63
Share price
0.36%
Change (1 day)
1.01%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): S$13.09

According to DaVita's latest financial reports the company's current EPS (TTM) is S$12.82. In 2024 the company made an earnings per share (EPS) of S$13.97 an increase over its 2023 EPS that were of S$9.64.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$13.09-6.29%
2024S$13.9744.94%
2023S$9.6427.26%
2022S$7.57-35.56%
2021S$11.7644.1%
2020S$8.1619.7%
2019S$6.81540.48%
2018S$1.06-76.07%
2017S$4.45-19.31%
2016S$5.51242.52%
2015S$1.61-62.87%
2014S$4.3313.43%
2013S$3.828.45%
2012S$3.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$27.04 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$12.98 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$18.62 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.41-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA